期刊文献+

假性醛固酮减少症Ⅱ型的临床和发病机制研究现状 被引量:4

Clinical manifestation and pathogenesis of Pseudohypoaldosteronism Type 2
下载PDF
导出
摘要 假性醛固酮减少症Ⅱ型(PHAⅡ)是一种极为罕见的常染色体显性遗传病。患者的主要临床特征包括高血钾、高血压、高血氯、代谢性酸中毒,同时肾小球滤过率正常。该病的发生是由于无赖氨酸激酶(WNK)1和WNK4基因的突变,导致肾小管多种离子转运蛋白功能异常,水钠潴留,钾离子分泌减少,这些蛋白功能异常可以用噻嗪类利尿剂纠正。 Pseudohypoaldosteronism Type 2 (PHA Ⅱ ) is a rare autosomal-dominant illness characterized by salt-dependent hypertension with hyperkalemia, slight hyper-chloremia, metabolic acidosis despite normal glnmerular filtration rate. The molecular defect of PI-IA Ⅱ was found to be mutations in WNK1 or WNK4 gene. These mutations could cause dysfunctions of the ion transporters in the distal nephron which result in salt retention and impaired potassium secretion. These abnormalities could be ameliorated by small doses of thiazide diuretics.
出处 《国际内科学杂志》 CAS 2007年第12期736-739,共4页 International Journal of Internal Medicine
关键词 假性醛固酮减少症Ⅱ型(PHAⅡ) 高血压 高血钾 WNK4 WNK1 Pseudohypoaldosteronism Type 2 Hypertension Hyperkalemia WNK1 WNK4
  • 相关文献

参考文献15

  • 1Wilson FH, Disse-Nicodeme S. Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science, 2001,293(5532) :1107-1112.
  • 2Gamba G. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. Am J Physiol Renal Physiol, 2005,288 (2):F245- F252.
  • 3Mansfield TA, Simon DB, Farfel Z, et al. Multilocus linkage of familial hyperkalaemia and hypertension pseudohypoaldosteronism type Ⅱ , to chromosomes 1q31-42 and 17p11-q21. Nat Genet, 1997,16(2):202-205.
  • 4Disse-Nicodeme S, Achard JM, Desitter I, et al. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type Ⅱ, an autosomal dominant from of hypertension. Am J Hum Genet, 2000,67 ( 2 ) :302-310.
  • 5Golhang AP, Murthy M, Hamad A, et al. A new kindred with pseudohypoaldosteronism type Ⅱ and a novel mutation (564D > H) in the acidic motif of the WNK4 Gene. Hypertension, 2005,46 ( 2 ) :295-300.
  • 6Xu B, English JM, Wilsbacher JL, et al. WNKI, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain Ⅱ. J Biol Chem, 2000,275(22) : 16795-16801.
  • 7Yang CL, Angell J, Mitchell R, et al. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest,2003,111(7):1039-1045.
  • 8Lalioti MD, Zhang J, Volkman HM, et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet, 2006,38 (10) : 1124-1132.
  • 9Lazrak A, Liu Z, Huang CL. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A, 2006,103 (5) : 1615-1620.
  • 10Xie J, Craig L, Cobb MH, et al. Role of with-no-lysine [k] kinases in the pathogenesis of Gordon's sydrome. Pediatr Nephrol, 2006,21 ( 9 ) : 1231-1236.

同被引文献23

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部